ALK and anaplastic large cell lymphoma: A recent study showed that CD147 was differentially expressed in systemic ALK (anaplastic lymphoma kinase)-positive ALCL (ALK+ ALCL) versus ALK-negative ALCL (ALK− ALCL) and normal T cells, as CD147 is a direct target of miR-146.